OKYO Pharma Inc - Volume dana dhuwit perusahaan OKYO

Simbol resmi perusahaan OKYO Pharma Limited (OKYO)

OKYO Pharma Limited management focuses on developing advanced treatments for dry eye syndrome. The company's success depends on the outcomes of clinical trials for its eye drops, which necessitates rigorous risk management. Robotic systems and bioinformatics accelerate the discovery of new compounds by eliminating routine tasks. The cash capital dynamics on the GURU.Markets portal are illustrated in this chart, where the parameter has stabilized at 0.02.

OKYO - Volume dana dhuwit perusahaan okyopharma.com ing rentang 27.06.2023 - 21.11.2026

Rincian metrik lan analitis perusahaan OKYO Pharma Limited (OKYO)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:OKYO Pharma Limited OKYO
Produk mawa merek OKYO Pharma Inc

This indicator reflects the total volume of liquid assets in the issuer's accounts, allowing investors to track the burn rate and the organization's financial autonomy in real time. By analyzing the cash structure of OKYO Pharma Limited, one can assess the company's ability to fund the development of ophthalmological drugs, which, combined with patent protection, ensures business sustainability and high future margins.